New test could help personalize treatment for common childhood cancer
Thursday, October 15, 2015 - 10:00
in Health & Medicine
A new gene test can identify which patients are likely to suffer more aggressive forms of the childhood cancer rhabdomyosarcoma, new research reports. Examining the activity of only five genes in a sample of the tumor was enough to identify high-risk children who might benefit from more intensive treatment or from new therapies in clinical trials.